Amprenavir
Back to searchMolecule Structure
Scientific Name
Amprenavir
Description of the Drug
Amprenavir is a protease inhibitor used to treat HIV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00701
http://www.drugbank.ca/drugs/DB00701
Brand Name(s)
Agenerase
Company Owner(s)
Glaxosmithkline
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34151 | ||
| PharmGKB | PA448422 | ||
| Human Metabolome Database | HMDB0014839 | ||
| DrugBank | DB00701 | ||
| PubChem: Thomson Pharma | 14884574 | 14835820 | |
| PubChem | 65016 | ||
| Mcule | MCULE-8147835017 | ||
| Nikkaji | J1.015.291G | ||
| PDBe | 478 | ||
| BindingDB | 577 | 50215393 | |
| DrugCentral | 200 | ||
| Brenda | 229162 | 1608 | 229161 |
| ChemicalBook | CB4186139 | ||
| rxnorm | AMPRENAVIR | ||
| PubChem: Drugs of the Future | 12014852 | ||
| KEGG Ligand | C08086 | ||
| ChEBI | 40050 | ||
| ZINC | ZINC000003809192 |
